Chambers and Partners has recognized Pomerantz LLP as one of the top plaintiffs’ securities litigation firms in the nation and in New York in 2020. Praising Pomerantz as “a prominent player on the plaintiffs' side,” Chambers credits the Firm for being a “highly regarded force [… ] known for taking on major corporate issuers.”

On April 22, 2020, Judge William F. Kuntz II in the U.S. District Court in the Eastern District of New York denied Blue Apron’s motion to dismiss our action in its entirety. In Re Blue Apron Holdings, Inc. Securities Litigation, alleges claims against Blue Apron, a subscription-based meal preparation service that went public in 2017.

On April 7, 2020, Pomerantz was appointed lead counsel in an action against Qudian Inc., concerning materially false and misleading statements regarding its response to regulatory developments in China that threatened to negatively impact Qudian’s full year 2019 financial results, when in reality Qudian’s business was unprepared to mitigate the risks associated with these changes.

On April 6, 2020, Pomerantz succeeded in both defeating the Defendants’ motion to dismiss the third amended complaint against Mylan Pharmaceuticals and in getting the class certified by Judge Oetken in the Southern District of New York.

On April 7, 2020, Pomerantz LLP was appointed Lead Counsel in a class action lawsuit against Domo, Inc., brought on by concerns that Domo and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.

On March 23, 2020, Pomerantz LLP was appointed Lead Counsel in a securities litigation class action lawsuit against Forescout Technologies, Inc.

On February 12, 2020, Pomerantz LLP was appointed Lead Counsel in a securities litigation class action lawsuit against Twitter, Inc, regarding its misrepresentation of “fixes” to user choice settings, which adversely affected its ability to deliver monetized advertisements.

On February 11, 2020, Pomerantz LLP was appointed Lead Counsel in a class action lawsuit against Canopy Growth Corporation, alleging that the Company issued false and/or misleading statements that exaggerated or overestimated the potential market for its legal recreational marijuana products in Canadian retail stores and consequently misrepresented its inventory, to its financial detriment..

On February 3, 2020, Pomerantz LLP was appointed Lead Counsel in a securities litigation class action lawsuit against PG&E Corporation, alleging that PG&E’s new, “enhanced” wildfire prevention and safety protocols were misrepresented as adequate, and that the Company was therefore unprepared for the rolling power cuts and their consequences, implemented in California in 2019.

On January 10, 2020, Pomerantz LLP was appointed Lead Counsel in a securities class action lawsuit against Zynerba Pharmaceuticals, Inc., regarding allegations that Zynerba failed to disclose details discovered in trials of its transdermal CBD gel product, Zygel.

On January 7, 2020, Pomerantz LLP was appointed Lead Counsel in a class action lawsuit against Match Group, Inc., regarding allegations that the Company failed to disclose adverse facts about its practice of bating customers of its dating products with fake love interest ads to convince customers to buy upgrades and making cancelling subscriptions difficult.

On January 2, 2020, Pomerantz LLP was appointed Lead Counsel in a securities litigation class action lawsuit against Eldorado Resorts, Inc., alleging that the Company’s business practices knowingly disregarded its business Code of Ethics and Business Conduct.

On December 27, 2019, Pomerantz LLP announced that it has filed a securities fraud lawsuit on behalf of several dozen institutional investors in conjunction with the ISAF-Danske Coalition (International Securities Associations and Foundations Management Company for Damaged Danske Investors).

On December 30, 2019, Pomerantz LLP was appointed Lead Counsel in a securities litigation class action lawsuit against Altria Group, Inc. and certain of its senior officers, concerning the nature of its investment into JUUL Labs, Inc in December, 2018.

On December 26, 2019, Pomerantz LLP was appointed Lead Counsel in a securities class action lawsuit against International Flavors & Fragrances, Inc, in the United States District Court for the Southern District of New York.

On December 17, 2019, Pomerantz LLP was appointed Lead Counsel in a securities litigation class action against Sarepta Therapeutics, Inc. and certain of its senior officers for violation of the federal securities laws.

On November 20, 2019, Pomerantz LLP was appointed Lead Counsel in Padilla v. Community Health Systems, Inc., a securities class action litigation in the Middle District of Tennessee.

On November 6, 2019, Pomerantz LLP was appointed lead counsel in a securities litigation class action lawsuit against Aclaris Therapeutics, Inc.

Pomerantz Managing Partner featured on Lawdragon. Read here!

http://www.lawdragon.com/2019/10/16/lawyer-limelight-jeremy-a-lieberman/